REDLAMP 10: Can Physical Activity Lower the Risk of Non-Hodgkin Lymphoma?

The association between physical activity and a lower risk of non-Hodgkin lymphoma is not well proven and few studies have established any link. However, Cancer Epidemiology, Biomarkers & Prevention published results from a case controlled study on physical activity and the risk of non-Hodgkin lymphoma. In this video Dr. Peter Martin explains the rationale of this case study, its findings, and important takeaways for people who may be at risk for non-Hodgkin lymphoma.

Previous #REDLAMP entries can be viewed on our Youtube channel.

We encourage you to follow the Lymphoma Program on Twitter, Youtube, and Facebook where we will highlight new videos are about research publications as they are released. We also welcome your feedback, suggestions and questions about this project. If you have other questions about our lymphoma program or clinical trials or would like to see one of our lymphoma specialists, please contact us at 212-746-2919.

Dr. Richard Furman Discusses Emerging Strategies for the Treatment of CLL & Follicular Lymphoma

In this video from Onc Live, Dr. Richard Furman, Director of the CLL Research Center discusses emerging strategies in the treatment of CLL and follicular lymphoma, specifically citing the use of venetoclax also known as ABT-199.

For patients with CLL the following trials are open to accrual.

Dr. John Leonard Discusses Ibrutinib Combined with Chemotherapy for Patients with Follicular Lymphoma

In this video clip from OncLive Lymphoma Program Director, John Leonard, MD discusses the phase III SELENE study, which examined the addition of ibrutinib to either R-CHOP or bendamustine plus rituximab for the treatment of patients with follicular lymphoma.

Other trials for follicular lymphoma can be found on our clinical trials listings.